Top Sell
Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Palisade Bio Inc. | 3 | 1 | 1 | 0 | €0.34 | €21.06 | 6072.333% |
Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.60 | €50.00 | 36.612% |
Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.34 | - | - |
Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €4.12 | - | - |
Agenus Inc. | 3 | 2 | 1 | 0 | €0.41 | €22.25 | 5276.897% |
Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €4.44 | - | - |
Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.41 | - | - |
Formycon AG | 3 | 1 | 0 | 0 | €44.35 | €100.00 | 125.479% |
Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.71 | €1.20 | -29.825% |
Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
Omeros Corp. | 2 | 4 | 0 | 0 | €3.13 | - | - |
Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.96 | €3.00 | 53.453% |
Gritstone Oncology Inc | 3 | 2 | 1 | 0 | €0.69 | €6.43 | 834.520% |
Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
Ocuphire Pharma Inc. | 6 | 1 | 1 | 0 | €1.55 | €18.37 | 1084.903% |
B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.87 | €30.00 | 945.296% |
Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.56 | €3.00 | 431.915% |
Medigene AG | 1 | 2 | 1 | 0 | €1.43 | €1.00 | -30.070% |
Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
Fate Therapeutics Inc. | 4 | 3 | 1 | 1 | €3.59 | €8.27 | 130.128% |
Minerva Neurosciences Inc. | 1 | 6 | 0 | 1 | €2.34 | €3.00 | 28.205% |
Trevena Inc. | 2 | 14 | 1 | 1 | €0.35 | €6.48 | 1778.841% |
Synthetic Biologics Inc. | 0 | 1 | 0 | 1 | €0.35 | - | - |
Savara Inc. | 1 | 1 | 0 | 1 | €4.62 | €8.00 | 73.160% |